Houlihan Lokey
HLI
125.22
-2.72
-2.13%
Houlihan Lokey
US · HLI
#1588 by market cap
Listed 2015
125.22
-2.72
-2.13%
Live - 5344 symbols - heartbeat 362s ago
· 2026-10-08 06:44
Pre-market
125.00
-0.18%
After-hours
125.22
0.00%
- Market cap
- 8.75B
- P/E (TTM)i
- 21.05
- P/Bi
- 3.88
- EPSi
- 6.22
- Div yieldi
- 2.00%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on HLI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 80.35% +0.09pp
- Institutions
- 591 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund67.77%
Hedge Fund6.12%
Individual/Insider4.90%
Public Company2.84%
Government Pension Fund1.09%
Private Company0.97%
Sovereign Wealth Fund0.94%
Family Office/Trust0.36%
Insurance Company0.19%
Other14.82%
Top holders as of 2026-06-30
BlackRock
7.50% · 5.24M sh
Vanguard Capital Management, LLC
3.98% · 2.78M sh
Vanguard Portfolio Management, LLC
3.97% · 2.77M sh
Kayne Anderson Rudnick Investment Management, LLC
3.47% · 2.43M sh
EARNEST Partners, LLC
3.11% · 2.17M sh
RBC Global Asset Management Inc.
2.72% · 1.90M sh
State Street Global Advisors
2.50% · 1.75M sh
Eaton Vance Management
2.11% · 1.48M sh
Geode Capital Management, LLC
1.98% · 1.38M sh
Burgundy Asset Management Ltd.
1.84% · 1.28M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 28 sells
| Name | Role | Stake |
|---|---|---|
| Irwin Gold | Executive Chairperson | 1.52% |
| Scott Adelson | Co-President, Senior MD of Corporate Finance Group & Director | 1.29% |
| Scott Beiser | Chief Executive Officer | 1.13% |
| Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | 0.57% |
| J. Alley | MD & CFO | 0.11% |
| Todd Carter | Managing Director | 0.11% |
| Christopher Crain | MD, General Counsel & Secretary | 0.07% |
| Robert Schriesheim | Lead Independent Director | 0.04% |
| Jacqueline Kosecoff | Independent Director | 0.02% |
| Cyrus Walker | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Thomas Reichert | Independent Director | Other Acquisition | +925 | -- |
| 2026-09-09 | Christopher Crain | MD, General Counsel & Secretary | Derivative Exercise and Sale | -1,000 | $140.15 |
| 2026-08-02 | J. Alley | MD & CFO | Open Market Acquisition | +4,020 | $124.52 |
| 2026-05-20 | Robert Schriesheim | Lead Independent Director | Other Acquisition | +1,129 | -- |
| 2026-05-20 | Scott Beiser | Chief Executive Officer | Derivative Exercise and Sale | -6,265 | $150.26 |
| 2026-05-20 | Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | Other Acquisition | +39,630 | -- |
| 2026-05-20 | Christopher Crain | MD, General Counsel & Secretary | Other Acquisition | +6,394 | -- |
| 2026-05-20 | J. Alley | MD & CFO | Other Acquisition | +7,100 | -- |
| 2026-05-20 | J. Alley | MD & CFO | Other Disposition | -7,100 | -- |
| 2026-05-20 | Scott Adelson | Co-President, Senior MD of Corporate Finance Group & Director | Other Acquisition | +34,548 | -- |
| 2026-05-20 | Paul Zuber | Independent Director | Other Acquisition | +797 | -- |
| 2026-05-20 | Cyrus Walker | Independent Director | Other Acquisition | +996 | -- |
| 2026-05-20 | Gillian Zucker | Independent Director | Other Acquisition | +996 | -- |
| 2026-05-20 | Ekpedeme Bassey | Independent Director | Other Acquisition | +797 | -- |
| 2026-05-20 | R. Mund | Independent Director | Other Acquisition | +476 | -- |
| 2026-05-18 | Christopher Crain | MD, General Counsel & Secretary | Sale to Issuer | -2,107 | $150.35 |
| 2026-05-14 | Irwin Gold | Executive Chairperson | Sale to Issuer | -4,619 | $150.35 |
| 2026-05-14 | Scott Beiser | Chief Executive Officer | Sale to Issuer | -6,497 | $150.35 |
| 2026-05-14 | Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | Sale to Issuer | -9,359 | $150.35 |
| 2026-05-14 | Todd Carter | Managing Director | Sale to Issuer | -13,707 | $150.35 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:44:44 · For reference only, not investment advice and not tailored to your situation.